In case you missed it: April 12 to April 16
It was a very busy week for the Contemporary OB/GYN team.
This week’s top articles included:
Dermatoses of Pregnancy
Curbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women.
AUGS Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder
Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.
ACOG Committee Opinion No. 825 advocates trauma-informed model of care
New guidance from the American College of Obstetrics and Gynecologists (ACOG) calls on ob/gyns to recognize the prevalence of trauma and its impact on patients and health care teams and outlines the importance of trauma-informed approaches to delivery of care.
FDA Approves New Oral Contraceptive Nextstellis
Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More
